Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2005

01-10-2005 | Article

Evaluation of the new Vitek 2 GN card for the identification of gram-negative bacilli frequently encountered in clinical laboratories

Authors: F. N. R. Renaud, E. Bergeron, S. Tigaud, C. Fuhrmann, B. Gravagna, J. Freney

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2005

Login to get access

Abstract

The new Vitek 2 GN card (bioMérieux, Marcy-l'Etoile, France) was developed for better identification of fermenting and nonfermenting bacilli. This new card allows the identification of 159 taxa. A total of 426 isolates (331 fermenting and 95 nonfermenting gram-negative bacilli) belonging to 70 taxa covered by the database were evaluated. All isolates were identified in parallel with the ID 32 GN, the API 20E, and the API 20NE methods. The system correctly identified 97.4% (n=415) of the strains. Only 2.1% (n=9) needed additional testing. One strain (0.25%) was misidentified (Klebsiella pneumoniae subsp. pneumoniae), and another one (0.25%) was not identified (Morganella morganii subsp. morganii). The new GN card gives more accurate identifications overall for gram-negative bacilli when compared to the systems described in other similar studies.
Literature
1.
go back to reference Funke G, Monnet D, DeBernardis C, von Graevenitz A, Freney J (1998) Evaluation of the Vitek 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 26:1948–1952 Funke G, Monnet D, DeBernardis C, von Graevenitz A, Freney J (1998) Evaluation of the Vitek 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 26:1948–1952
2.
go back to reference Jossart MF, Courcol RJ (1999) Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur J Clin Microbiol Infect Dis 18:902–907PubMedCrossRef Jossart MF, Courcol RJ (1999) Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur J Clin Microbiol Infect Dis 18:902–907PubMedCrossRef
3.
go back to reference Joyanes P, del Carmen Conejo M, Martinez-Martinez L, Perea E (2001) Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 39:3247–3253PubMedCrossRef Joyanes P, del Carmen Conejo M, Martinez-Martinez L, Perea E (2001) Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 39:3247–3253PubMedCrossRef
4.
go back to reference Ling TKW, Tam PC, Liu ZK, Chieng AFB (2001) Evaluation of Vitek 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol 39:2964–2966CrossRefPubMed Ling TKW, Tam PC, Liu ZK, Chieng AFB (2001) Evaluation of Vitek 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol 39:2964–2966CrossRefPubMed
5.
go back to reference Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR (2002) Evaluation of the Vitek-2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 21:869–874PubMed Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR (2002) Evaluation of the Vitek-2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 21:869–874PubMed
6.
go back to reference O’Hara CM, Miller JM (2003) Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ Card. J Clin Microbiol 41:2096–3101CrossRefPubMed O’Hara CM, Miller JM (2003) Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ Card. J Clin Microbiol 41:2096–3101CrossRefPubMed
7.
go back to reference Funke G, Funke-Kissling P (2004) Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods. J Clin Microbiol 42:4067–4071CrossRefPubMed Funke G, Funke-Kissling P (2004) Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods. J Clin Microbiol 42:4067–4071CrossRefPubMed
Metadata
Title
Evaluation of the new Vitek 2 GN card for the identification of gram-negative bacilli frequently encountered in clinical laboratories
Authors
F. N. R. Renaud
E. Bergeron
S. Tigaud
C. Fuhrmann
B. Gravagna
J. Freney
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-0026-6

Other articles of this Issue 10/2005

European Journal of Clinical Microbiology & Infectious Diseases 10/2005 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.